SCHEMBL8286558

SCHEMBL8286558

Cc1cc2c(c(NCC(=O)N3CCOCC3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.46
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HTT P42858 1/20 0.39
PTGS2 P35354 1/20 0.39
ACHE P22303 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
IGF1R P08069 1/20 0.37
PIM1 P11309 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358804 0.86 MAT2A (0.41) PDE11AALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL8287409 0.85 PDE11A (0.51) PDE11AALDH1A1KDM4EHTTPTGS2
SCHEMBL8285337 0.84 HSP90AA1 (0.47) PDE11AALDH1A1KDM4EMEN1KMT2A
SCHEMBL8285340 0.84 PDE11A (0.45) PDE11AALDH1A1KDM4EPKMSMN1; SMN2
SCHEMBL8286535 0.83 OPRK1 (0.45) PDE11AALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL5871913 0.81 ALDH1A1 (0.42) ALDH1A1KDM4EHTTMEN1KMT2A
SCHEMBL8287944 0.79 GAA (0.43) PDE11AALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL8287403 0.79 PDE11A (0.56) PDE11AALDH1A1KDM4EHTTPKM
SCHEMBL8287419 0.79 PDE11A (0.51) PDE11AALDH1A1KDM4EMEN1KMT2A
SCHEMBL8287591 0.78 LMNA (0.42) PDE11AALDH1A1KDM4EHTTPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed